Abnormal levels of maternal serum human chorionic gonadotropin and alpha‐fetoprotein in the second trimester: Relation to fetal weight and preterm delivery

Prenatal Diagnosis

Volumn 15, Issue 11, 1995, Pages 1041-1046

  Morssink, L P ^a   Kornman, L H ^a   Beekhuis, J R ^a   de Wolf, B T H M ^a   Mantingh, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

fetal weight; maternal serum alpha fetoprotein (MSAFP); maternal serum human chorionic gonadotropin (MShCG); preterm delivery

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ARTICLE; DELIVERY; FETUS; FETUS WEIGHT; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREMATURITY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ALPHA-FETOPROTEINS; BIRTH WEIGHT; CHORIONIC GONADOTROPIN; FEMALE; HUMAN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; INFANT, VERY LOW BIRTH WEIGHT; LABOR, PREMATURE; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 0028971343     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1970151109     Document Type: Article

References (23)

1. Increased maternal serum alpha‐fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome
2. Elevated maternal serum a‐fetoprotein levels associated with breakdown in fetal–maternal–placental barrier
3. Elevated maternal serum alpha‐fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies
4. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies
5. Why might maternal serum AFP be high in pregnancies in which the fetus is normally formed?
6. Raised maternal serum alpha‐fetoprotein in the absence of fetal abnormality—placental findings. A quantitative morphometric study
7. Unexplained elevated maternal serum a‐fetoprotein levels and perinatal outcome in an urban clinic population
8. Significance of elevated mid‐trimester maternal plasma‐alpha‐fetoprotein values
9. Unexplained elevated maternal serum alpha‐fetoprotein and adverse perinatal outcome
10. Mid‐trimester levels of alphafetoprotein in the screening of low birth‐weight
11. Risks associated with an elevated maternal serum a‐fetoprotein level
12. The association between unexplained second‐trimester maternal serum hCG elevation and pregnancy complications
13. Placental histology and the production of human choriogonadotrophin and its subunits in pregnancy
14. On intrauterine growth, the significance of prenatal care
15. Raised maternal serum‐alpha‐fetoprotein levels and spontaneous fetomaternal transfusion
16. Origin of raised maternal serum alpha‐fetoprotein levels in second‐trimester oligohydramnios
17. Unexplained elevation in maternal serum alpha‐fetoprotein and subsequent fetal loss
18. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths
19. Outcomes in patients with unusually high maternal serum a‐fetoprotein levels
20. Mid‐trimester biochemistry in prediction of third trimester complications
21. Maternal serum‐alpha‐fetoprotein and low birth‐weight
22. Alpha‐fetoprotein: a biomarker for pregnancy outcome
23. Elevated second‐trimester human chorionic gonadotropin levels in association with poor pregnancy outcome